Zanamivir是一种特异性作用于流感病毒神经氨酸酶的有效抑制剂。
|
英文别名 (English Synonym) |
Zanamivir |
|
中文名称 (Chinese Name) |
扎那米韦 |
|
靶点 (Target) |
NA |
|
通路 (Pathway) |
Microbiology/Virology |
|
CAS号 (CAS NO.) |
139110-80-8 |
|
分子式 (Formula) |
C12H20N4O7 |
|
分子量 (Molecular Weight) |
332.31 |
|
纯度 (Purity) |
≥98% |
|
溶解性 (Solubility) |
溶于H2O |
-25~-15℃保存，有效期3年
[1] McKimm-Breschkin JL. Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance. Treat Respir Med. 2005;4(2):107-16. doi: 10.2165/00151829-200504020-00004. PMID: 15813662; PMCID: PMC7099216. [2] Shanmugam S, Im HT, Sohn YT, Kim KS, Kim YI, Yong CS, Kim JO, Choi HG, Woo JS. Zanamivir oral delivery: enhanced plasma and lung bioavailability in rats. Biomol Ther (Seoul). 2013 Mar;21(2):161-9. doi: 10.4062/biomolther.2013.010. PMID: 24009875; PMCID: PMC3762309.
